Mon, May 15, 2023
Fri, May 12, 2023
Thu, May 11, 2023

Andrew Fein Reiterated (AMLX) at Strong Buy and Held Target at $50 on, May 12th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-50-on-may-12th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Reiterated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $50 on, May 12th, 2023.

Andrew has made no other calls on AMLX in the last 4 months.



There are 3 other peers that have a rating on AMLX. Out of the 3 peers that are also analyzing AMLX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $47 on, Tuesday, March 14th, 2023


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Graig Suvannavejh of "Mizuho" Initiated at Strong Buy and Held Target at $52 on, Friday, March 31st, 2023
  • Itay Michaeli of "Citigroup" Maintained at Strong Buy with Increased Target to $54 on, Tuesday, March 14th, 2023

Publication Contributing Sources